Canary's staked Injective ETF goes live on Nasdaq as $INJC

Canary's staked Injective ETF is now live on Nasdaq, trading under the ticker $INJC. Cointelegraph flagged the debut, noting the fund arrives with a staking twist baked in rather than sitting on idle tokens.

The headline number: at least 90% of the ETF's INJ holdings are being staked, according to Bloomberg ETF analyst James Seyffart. That means the bulk of the fund's exposure isn't just parked — it's put to work on Injective's network.

Injective's INJ token is the asset behind the product, and the staked structure is the detail drawing attention. Most crypto ETFs hold the underlying asset cold; this one leans on network rewards instead.

Seyffart's post on the launch is the source for the staking figure, per Cointelegraph. Beyond the ticker and the 90%-plus staking threshold, details on fees, seed capital or issuer partners weren't laid out in the announcement.

For now, the takeaway is simple: a staked Injective product has cleared the runway and is trading on a major US exchange. Watch for inflows and how the staking mechanics get reported in the fund's disclosures.